During the past decade, Delaware Valley Urology, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delaware Valley Urology, LLC" #1 collaborator was "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Delaware Valley Urology, LLC" are "Benign Prostatic Hypertrophy" (2 trials), "Bladder Cancer" (2 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Delaware Valley Urology, LLC" in a lesser frequency.

Most popular intervention types in "Delaware Valley Urology, LLC" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (2 trials), "Cetrorelix 78 mg + 52 mg" (1 trials), "Cetrorelix 78 mg + 78 mg" (1 trials) and "Cetrorelix Pamoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delaware Valley Urology, LLC" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Delaware Valley Urology, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Delaware Valley Urology, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Delaware Valley Urology, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".